Nurix Therapeutics, Inc. (NRIX) has a market capitalization of $1.41B and trades at $16.30. The 52-week range is 8.18-22.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.3, Earnings Per Share (EPS) of $-3.05, annual revenue of $83.98M.
The stock has a beta of 2.02, operates in the Healthcare sector.
